Psoriasis Completed Phase 2 Trials for Acitretin (DB00459)

Also known as: Psoriasis unspecified / Psoriasis, unspecified

IndicationStatusPhase
DBCOND0013339 (Psoriasis)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00395941Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With PsoriasisTreatment
NCT00156247Acitretin and Etanercept in PsoriasisTreatment